Original Article
Oral microbial alterations by smoking and metabolic factors in esophageal squamous cell carcinoma
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1796-1811
.
(31 October 2025)
Impact of maintenance therapy with fluoropyrimidines in advanced esophageal-gastric adenocarcinoma: a retrospective study in Mexican population
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1812-1819
.
(31 October 2025)
Deciphering the immunometabolic axis: a mendelian randomization study of a causal cascade network from immune cell phenotypes to metabolites in esophageal cancer
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1820-1836
.
(31 October 2025)
Expression and clinical significance of ERBB4 in gastric cancer
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1837-1849
.
(31 October 2025)
Predictive factors for successful conversion therapy in gastric cancer with peritoneal metastasis: a case-control study
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1850-1861
.
(31 October 2025)
Integrated bioinformatic and machine learning analysis identifies MCM7 and ADAM17 as potential biomarkers for early stage gastric cancer
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1862-1877
.
(31 October 2025)
Prognostic factors for overall survival in patients with early gastric cancer: a retrospective cohort study based on SEER database
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1878-1889
.
(31 October 2025)
Trends and incidence of stomach cancer in middle-aged and elderly populations: a global burden of disease analysis
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1890-1901
.
(31 October 2025)
Stemness-based gastric cancer classification by machine learning for precision diagnosis and treatment of gastric cancer
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1902-1923
.
(31 October 2025)
Global, regional, and national burden of gastrointestinal cancers in early onset and young women, 1990–2021: analysis of data from the Global Burden of Disease study 2021
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1924-1943
.
(31 October 2025)
A promising model for prediction of chemotherapeutic sensitivity in gastrointestinal cancers using patient-derived malignant ascites organoids
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1944-1961
.
(31 October 2025)
Disparities in gastrointestinal cancer trials recruitment: analyzing demographic gaps compared to the real-world
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1962-1970
.
(31 October 2025)
Preoperative prediction of tumor budding in colorectal cancer based on quantitative parameters of dual-layer detector spectral computed tomography: a preliminary study
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1971-1984
.
(31 October 2025)
Prognostic and safety analysis of capecitabine monotherapy versus CapeOx (capecitabine plus oxaliplatin) in elderly patients with high-risk stage II and stage III MRD-negative colorectal cancer
Journal of Gastrointestinal Oncology
2025;
16
(5)
:1985-2000
.
(31 October 2025)
Clinical outcomes of third-line chemotherapy prior to best supportive care in patients with stage IV colorectal cancer: a single-center study from Japan
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2001-2012
.
(31 October 2025)
Integrating nutritional and immune-inflammation-based index predicts disease-free survival of colorectal cancer patients undergoing radical surgery
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2013-2025
.
(31 October 2025)
ISM2 as a prognostic biomarker and mediator of immune infiltration in colorectal cancer: evidence from bioinformatics and experimental analysis
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2026-2043
.
(31 October 2025)
Molecular and clinical registry of Chilean patients diagnosed with BRAF-mutated colorectal cancer
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2044-2057
.
(31 October 2025)
Evaluating the cross-reactivity of a stool methylated syndecan-2 (meSDC2) test in colorectal cancer detection
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2058-2066
.
(31 October 2025)
Prognostic nomogram for colorectal cancer liver metastasis treated with tumor resection and chemotherapy based on SEER database
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2067-2083
.
(31 October 2025)
Body mass index-defined overweight (but not obese) correlates with better postoperative prognosis in colorectal cancer
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2084-2100
.
(31 October 2025)
Study on ensemble model with weight allocation based on improved dung beetle optimization algorithm for screening colorectal cancer using laboratory test indicators
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2101-2115
.
(31 October 2025)
Construction of conditional survival nomograms for metastatic early onset colon cancer patients
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2116-2126
.
(31 October 2025)
Bioinformatics analysis of TCGA data identifies a taurine metabolism-related subtype classification for predicting prognosis in colon adenocarcinoma
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2127-2137
.
(31 October 2025)
Ethnic and socioeconomic disparities in survival outcomes among patients under 65 years with intrahepatic cholangiocarcinoma: a SEER analysis
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2138-2145
.
(31 October 2025)
Safety and efficacy of liver-directed radiotherapy after chemoimmunotherapy for advanced cholangiocarcinoma: an early report from a large tertiary cancer center
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2146-2157
.
(31 October 2025)
Global, regional, and national burden of liver cancer attributable to hepatitis B virus among middle-aged and older adults from 1990 to 2021 and projections to 2035: results of the Global Burden of Disease Study 2021
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2158-2175
.
(31 October 2025)
Comprehensive bioinformatic analysis reveals sorafenib response-related prognostic signature in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2176-2192
.
(31 October 2025)
Quantitative assessment of multi-phase contrast-enhanced CT features in hepatic epithelioid hemangioendothelioma
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2193-2202
.
(31 October 2025)
Financial toxicity in patients with newly diagnosed hepatocellular carcinoma: a cross-sectional study
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2203-2212
.
(31 October 2025)
Relationship between spontaneous rupture of hepatocellular carcinoma (SRHCC) and long-term survival after anatomic liver resection
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2213-2224
.
(31 October 2025)
YTHDF1 regulates YTHDF2 stability via m6A-dependent mechanisms in hepatocellular carcinoma: insights from in vitro, in vivo, and multi-cohort clinical studies
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2225-2244
.
(31 October 2025)
CYSTM1 is a potential diagnostic and prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2245-2261
.
(31 October 2025)
Prognostic value of a simplified score based on routine parameters in patients with hepatocellular carcinoma treated with systemic therapies: a retrospective cohort study
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2262-2273
.
(31 October 2025)
ZNF529 up-regulation speeds up progression and induces tyrosine kinase inhibitor resistance in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2274-2288
.
(31 October 2025)
Development and validation of a GP73-based predictive model for the diagnosis of early-stage hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2289-2301
.
(31 October 2025)
Construction of a predictive model for gemcitabine combined with cisplatin resistance in intrahepatic cholangiocarcinoma based on multidimensional inflammatory indices
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2302-2313
.
(31 October 2025)
STRIP2 promotes hepatocellular carcinoma progression and immune evasion: a potential prognostic biomarker and therapeutic target
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2314-2335
.
(31 October 2025)
A combination of MRI diffusion-derived vessel density (DDVD) and slow diffusion coefficient (SDC) can reliably diagnose liver hemangioma: a testing of three centers’ data
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2336-2356
.
(31 October 2025)
The SNHG3/miR-148a-3p axis-mediated high expression of DNMT1 is correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2357-2376
.
(31 October 2025)
Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2377-2387
.
(31 October 2025)
Identification of key genes in pancreatic ductal adenocarcinoma with biologically informed deep neural network
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2388-2401
.
(31 October 2025)
Review Article
Recent advancements in systemic therapy for biliary tract cancers: a literature review
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2402-2429
.
(31 October 2025)
Study Protocol
Adebrelimab combined with anlotinib plus hepatic arterial infusion chemotherapy or intravenous chemotherapy for first-line treatment of advanced biliary tract cancer: protocol for a randomized open-label clinical study
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2430-2440
.
(31 October 2025)
Surgical Technique
Clinical application of indocyanine green fluorescence imaging technology in laparoscopic rectal cancer surgery
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2441-2451
.
(31 October 2025)
Fluorescence-guided laparoscopic-assisted transabdominal intersphincteric resection for ultralow rectal cancer: report of a surgical technique
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2452-2460
.
(31 October 2025)
Application of modified laparoscopic stomach-partitioning gastrojejunostomy for stage IV gastric cancer with gastric outlet obstruction
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2461-2471
.
(31 October 2025)
Fluorescence-guided laparoscopic resection of liver segment 4 plus the right anterior ventral section for hepatocellular carcinoma adjacent to the left hepatic pedicle and middle hepatic vein: a case report
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2472-2484
.
(31 October 2025)
Case Report
Atypical abdominal pain: uncovering malignant peritoneal mesothelioma in suspected Crohn’s disease: a case report
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2485-2491
.
(31 October 2025)
Extramedullary metastasis of the hilar bile duct in multiple myeloma: a case report and literature review
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2492-2498
.
(31 October 2025)
Editorial
Investigating survival patterns in pancreatic adenocarcinoma over two decades after introducing FOLFIRINOX
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2499-2501
.
(31 October 2025)
Spotlight on AMIGO2 as a novel prognostic indicator in pancreatic cancer
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2502-2505
.
(31 October 2025)
D3 lymph node dissection in right-sided colon cancer: routine requirement or selective application?
Journal of Gastrointestinal Oncology
2025;
16
(5)
:2506-2514
.
(31 October 2025)
